Autism-associated neuroligin-3 mutations commonly disrupt tonic endocannabinoid signaling
about
A novel computational biostatistics approach implies impaired dephosphorylation of growth factor receptors as associated with severity of autism.β-Neurexins Control Neural Circuits by Regulating Synaptic Endocannabinoid SignalingDistinct circuit-dependent functions of presynaptic neurexin-3 at GABAergic and glutamatergic synapses.Autism-associated neuroligin-3 mutations commonly impair striatal circuits to boost repetitive behaviors.Mouse Genetic Models of Human Brain DisordersAutism Spectrum Disorders and Drug Addiction: Common Pathways, Common Molecules, Distinct Disorders?GABAergic signaling as therapeutic target for autism spectrum disordersNeuroligins provide molecular links between syndromic and nonsyndromic autismDeveloping Medications Targeting Glutamatergic Dysfunction in Autism: Progress to DateOn the Teneurin track: a new synaptic organization molecule emergesPersistent inhibitory circuit defects and disrupted social behaviour following in utero exogenous cannabinoid exposureA neuroligin-3 mutation implicated in autism causes abnormal aggression and increases repetitive behavior in miceEndocannabinoid signaling in social functioning: an RDoC perspectiveThe interplay between synaptic activity and neuroligin function in the CNSp21-activated kinase 1 restricts tonic endocannabinoid signaling in the hippocampusSynaptic proteins and receptors defects in autism spectrum disordersShank3-mutant mice lacking exon 9 show altered excitation/inhibition balance, enhanced rearing, and spatial memory deficit.Endogenous cannabinoid signaling at inhibitory interneurons.Novel 3D microscopic analysis of human placental villous trees reveals unexpected significance of branching angles.Synapses as therapeutic targets for autism spectrum disorders: an international symposium held in pavia on july 4th, 2014Perinatal exposure to bisphenol-A impairs spatial memory through upregulation of neurexin1 and neuroligin3 expression in male mouse brain.Identifying novel interventional strategies for psychiatric disorders: integrating genomics, 'enviromics' and gene-environment interactions in valid preclinical models.De novo TBR1 mutations in sporadic autism disrupt protein functions.Medical marijuana: review of the science and implications for developmental-behavioral pediatric practice.Autism-associated mutation inhibits protein kinase C-mediated neuroligin-4X enhancement of excitatory synapses.Altered network topologies and hub organization in adults with autism: a resting-state fMRI studyNovel interactive partners of neuroligin 3: new aspects for pathogenesis of autism.Defects in fatty acid amide hydrolase 2 in a male with neurologic and psychiatric symptoms.Abnormal Astrocytosis in the Basal Ganglia Pathway of Git1(-/-) Mice.Increased Cortical Inhibition in Autism-Linked Neuroligin-3R451C Mice Is Due in Part to Loss of Endocannabinoid SignalingMultiple Forms of Endocannabinoid and Endovanilloid Signaling Regulate the Tonic Control of GABA Release.Neuroligins Sculpt Cerebellar Purkinje-Cell Circuits by Differential Control of Distinct Classes of Synapses.Cytokine-dependent bidirectional connection between impaired social behavior and susceptibility to seizures associated with maternal immune activation in mice.Endocannabinoid Signaling in AutismSelective Dysregulation of Hippocampal Inhibition in the Mouse Lacking Autism Candidate Gene CNTNAP2.Advancing multiscale structural mapping of the brain through fluorescence imaging and analysis across length scales.Programming of neural cells by (endo)cannabinoids: from physiological rules to emerging therapies.Monogenic mouse models of autism spectrum disorders: Common mechanisms and missing links.Imbalance of excitatory/inhibitory synaptic protein expression in iPSC-derived neurons from FOXG1(+/-) patients and in foxg1(+/-) miceEndocannabinoid Mediates Excitatory Synaptic Function of β-Neurexins. Commentary: β-Neurexins Control Neural Circuits by Regulating Synaptic Endocannabinoid Signaling.
P2860
Q24612710-BE3D5981-E71F-49D8-9549-8CAD63644ACAQ26269814-DB400E42-50B1-4A11-BBB6-7B789AA06953Q26269827-D405D501-7922-41F2-BFAB-960B3C89DDC0Q26269833-4A153BDA-8BAE-4E18-AF3B-5618A13B9C47Q26752246-0E6BF633-3675-42A6-8FB6-319762241F7FQ26768231-76E223BF-7DFB-4FD1-97FF-4E5DCA267DF8Q27013583-36030A01-1742-4107-91D9-0C59C1B81E47Q27015370-8974A8BB-30AB-4DC2-A227-4CE3911FF44FQ27025683-F0817552-C41F-40FE-AB80-E36C521D0789Q27028029-2B1B1DC0-FE5A-4CF0-94F3-CB85535E3A27Q27318731-F86B8137-9BD1-45DB-8496-F4554A8AFC65Q27323118-51AB80AC-4B7A-494A-A81F-A49C983D1156Q28067103-D8F74A6D-E3C4-4772-8BBF-711CA1D34A70Q28084648-538EF93B-D6AB-4050-AC7D-B89F2DDC7A40Q28830314-1413F77E-6895-4FD9-9080-49FBDD79E228Q30009298-EC52C8C2-E513-453E-BC67-79F0DC272120Q30629661-E9422F62-3BC2-47A5-B377-ACB9EB9497FEQ33624983-564CB2CA-BAE3-4DB3-A1AB-5F99F929295CQ34085871-6FFBFFBC-4145-4AC7-B5A2-63069CE71518Q34264917-E57B3103-0074-43FC-AF05-82E50BB84F02Q34362211-311BF0B6-1E73-4CFA-B7C9-411606AC2152Q34407170-0884D3FC-9E68-4AD1-86CD-D39A59C4F4BFQ34419403-4D112178-4984-4C3B-BE2D-00CA285515BCQ35053208-60925556-C0B7-47F8-9ED4-30EF24ACC072Q35134823-565DA7B6-CDAF-454F-A465-B637EA93A87BQ35143184-3652B0F4-70BD-41DF-AA95-4CF4A8287D94Q35479781-9958AE84-9975-49DB-9C32-F4E46C7D2A25Q35579901-3674AB56-BB85-4A6E-A83B-61BAE47E2A86Q35749730-CE2D6A68-61E0-4D6B-9ECF-A262584FAB88Q35808385-7EEB9767-3C27-4FD4-8EAC-D1B033EE73ABQ35829479-7D0F0433-600D-4E43-834D-6D91B1786B9BQ35984604-CB18705D-B24D-45AE-931A-1A9CA35F4F6CQ36037266-A288956B-A73B-4ACB-B0DF-A013EA2B33D6Q36157617-F057148C-3B14-47A4-B502-2F79C82363E3Q36215384-87D30C97-2AEE-47B8-8623-63FA2F4ED2A0Q36390749-C5D390ED-3B40-4843-8823-0B369CAEFF5AQ36612284-4129A7A5-077F-48F3-AED6-B0C801F4244EQ36716971-4CF7EEAB-5D6B-4528-B9B0-4B3730D194F0Q36763149-6CD72F31-ED4C-417F-ABFE-81B538660CD7Q36918320-C9A3E7FF-795C-41B0-947F-10BE2AF4C32D
P2860
Autism-associated neuroligin-3 mutations commonly disrupt tonic endocannabinoid signaling
description
2013 nî lūn-bûn
@nan
2013 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Autism-associated neuroligin-3 mutations commonly disrupt tonic endocannabinoid signaling
@ast
Autism-associated neuroligin-3 mutations commonly disrupt tonic endocannabinoid signaling
@en
Autism-associated neuroligin-3 mutations commonly disrupt tonic endocannabinoid signaling
@nl
type
label
Autism-associated neuroligin-3 mutations commonly disrupt tonic endocannabinoid signaling
@ast
Autism-associated neuroligin-3 mutations commonly disrupt tonic endocannabinoid signaling
@en
Autism-associated neuroligin-3 mutations commonly disrupt tonic endocannabinoid signaling
@nl
prefLabel
Autism-associated neuroligin-3 mutations commonly disrupt tonic endocannabinoid signaling
@ast
Autism-associated neuroligin-3 mutations commonly disrupt tonic endocannabinoid signaling
@en
Autism-associated neuroligin-3 mutations commonly disrupt tonic endocannabinoid signaling
@nl
P2860
P3181
P1433
P1476
Autism-associated neuroligin-3 mutations commonly disrupt tonic endocannabinoid signaling
@en
P2093
Csaba Földy
P2860
P304
P3181
P356
10.1016/J.NEURON.2013.02.036
P407
P577
2013-05-08T00:00:00Z